<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>KFF Health News</provider_name><provider_url>https://kffhealthnews.org</provider_url><author_name>brilabuskes</author_name><author_url>https://kffhealthnews.org/news/author/brilabuskes/</author_url><title>Tying Drug Prices To What Other Countries Pay: A Pioneering Way To Curb Costs Or The Death Knell For Innovation? - KFF Health News</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="osODb2hACp"&gt;&lt;a href="https://kffhealthnews.org/morning-breakout/tying-drug-prices-to-what-other-countries-pay-a-pioneering-way-to-curb-costs-or-the-death-knell-for-innovation/"&gt;Tying Drug Prices To What Other Countries Pay: A Pioneering Way To Curb Costs Or The Death Knell For Innovation?&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/tying-drug-prices-to-what-other-countries-pay-a-pioneering-way-to-curb-costs-or-the-death-knell-for-innovation/embed/#?secret=osODb2hACp" width="600" height="338" title="&#x201C;Tying Drug Prices To What Other Countries Pay: A Pioneering Way To Curb Costs Or The Death Knell For Innovation?&#x201D; &#x2014; KFF Health News" data-secret="osODb2hACp" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
/* ]]&gt; */
&lt;/script&gt;
</html><description>The plan to tie prices of drugs to what other countries pay is a lightning rod in the debate over high drug costs. &#x201C;The countries in the reference pricing have longer life expectancy, better health outcomes, and spend about half of what we on health care,&#x201D; says David Mitchell, the president of Patients for Affordable Drugs. On the other side, is PhRMA's Jenny Bryant, who calls the proposal "draconian" and believes it will stifle innovation. Meanwhile, Republicans are siding with the latter position.</description></oembed>
